These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17665548)

  • 1. Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis.
    Nakamura H; Nakaji G; Shimazu H; Yasuda S; Odashiro K; Maruyama T; Kaji Y; Chishaki A
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):270-6. PubMed ID: 17665548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S
    Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric emptying and electrogastrography in reflux esophagitis: results in patients showing endoscopically erosive esophagitis under proton pump inhibitor therapy.
    Kudara N; Chiba T; Suzuki K
    Hepatogastroenterology; 2010; 57(101):772-6. PubMed ID: 21033227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA; Lipatova TE; Chaplygin NV
    Eksp Klin Gastroenterol; 2002; (2):43-6, 102. PubMed ID: 12046386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study.
    Kinoshita Y; Hongo M;
    Am J Gastroenterol; 2012 Apr; 107(4):522-30. PubMed ID: 22433921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study.
    Weigl M; Gschwantler M; Gatterer E; Finsterer J; Stöllberger C
    South Med J; 2003 Nov; 96(11):1128-32. PubMed ID: 14632362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA
    Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC
    Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
    [No Abstract]   [Full Text] [Related]  

  • 13. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type].
    Ivanova NG
    Eksp Klin Gastroenterol; 2002; (2):35-6, 101. PubMed ID: 12046384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of esophagitis/vagitis-induced paroxysmal atrial fibrillation by proton-pump inhibitors.
    Stöllberger C; Finsterer J
    J Gastroenterol; 2003; 38(11):1109. PubMed ID: 14673734
    [No Abstract]   [Full Text] [Related]  

  • 16. [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA; Lipatova TE; Chaplygin NV
    Eksp Klin Gastroenterol; 2002; (4):23-6, 131. PubMed ID: 12503269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
    Endo M; Sugihara K
    Nihon Rinsho; 2000 Sep; 58(9):1865-70. PubMed ID: 11004817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.